Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
194.080375584
InChI
InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)
InChI Key
InChIKey=SIQPXVQCUCHWDI-UHFFFAOYSA-N
IUPAC Name
3-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
Traditional IUPAC Name
enprofylline
SMILES
CCCN1C2=C(NC=N2)C(=O)NC1=O
pKa (strongest acidic)
7.83
pKa (Strongest Basic)
-0.77
Refractivity
49.31 m3·mol-1
Dược Lực Học :
Enprofylline is a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine. It antagonizes erythrocyte phosphodiesterase, increasing cAMP activity.
Cơ Chế Tác Dụng :
Enprofylline is a derivative of theophylline which shares bronchodilator properties. Enprofylline is used in asthma, chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy. Long-term enprofylline administration may be associated with elevation in liver enzyme levels and unpredictable blood levels.
Enprofylline inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, enprofylline also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity.
Dược Động Học :
▧ Absorption :
Rapidly absorbed from the digestive tract
▧ Protein binding :
49%
▧ Half Life :
1.9 hours
Chỉ Định :
Used in the management of symptoms of asthma. Also used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.